Effect of antibiotic prophylaxis on the risk of surgical site infection in orthotopic liver transplant
✍ Scribed by Angel Asensio; Antonio Ramos; Valentin Cuervas-Mons; Elisa Cordero; Victor Sánchez-Turrión; Marino Blanes; Carlos Cervera; Joan Gavalda; Jose M. Aguado; Julian Torre-Cisneros
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 117 KB
- Volume
- 14
- Category
- Article
- ISSN
- 1527-6465
- DOI
- 10.1002/lt.21435
No coin nor oath required. For personal study only.
✦ Synopsis
Surgical site infections are common bacterial infections in orthotopic liver transplantation. The purpose of this study was to determine the incidence, timing, location, and risk factors, specifically antibiotic prophylaxis, for surgical site infections. A prospective study was performed that included a population of 1222 consecutive patients (73.0% males) who underwent liver transplantation in Spanish hospitals belonging to the Red de Estudio de la Infección en el Trasplante research network. One hundred seven patients developed surgical site infections. The predominant infection sites were incisional wound (53 episodes) and peritonitis (40 episodes). The timing of the organ/space surgical site infections was slightly delayed in comparison with incisional surgical site infections. Enterococcus spp., Escherichia coli, Staphylococcus aureus, and Acinetobacter baumannii were the predominant pathogens. Choledochojejunal or hepaticojejunal reconstruction (odds ratio, 4.2; 95% confidence interval, 1.6-10.7), previous liver or kidney transplant (odds ratio, 2.6; 95% confidence interval, 1.1-6.3), and more than 4 red blood cell units transfused (odds ratio, 2.0; 95% confidence interval, 1.1-3.4) were independently associated with the development of surgical site infections. Biliary reconstruction by choledochojejunostomy or hepaticojejunostomy increases the risk of surgical site infections.
📜 SIMILAR VOLUMES
We sought to determine whether the prophylactic use of amphotericin B products (conventional amphotericin B and liposomal amphotericin B) reduces the incidence of fungal infections in high-risk liver transplant recipients, and if so, whether this lowers the cost of care. The study sample comprised 2
Prevention of fungal infections following liver transplantation is an important goal, and I appreciate the efforts of Reed et al. 1 to determine the efficacy of prophylactic amphotericin B (AMPH) in high-risk liver transplant recipients. In their study, fungi were isolated from 37 anatomic sites in
Objective: The purpose of this study was to determine if the prevalence of neonatal and maternal infectious morbidity in patients with preterm premature rupture of membranes (PROM) who received ampicillin prophylaxis for presemptive group B streptococcal colonization is increased compared to those w